Better Therapeutics (BTTX) Competitors $0.0001 0.00 (0.00%) As of 11:32 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock BTTX vs. UPHL, OPGN, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, and TALKWShould you be buying Better Therapeutics stock or one of its competitors? The main competitors of Better Therapeutics include UpHealth (UPHL), OpGen (OPGN), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), and Talkspace (TALKW). These companies are all part of the "healthcare" industry. Better Therapeutics vs. Its Competitors UpHealth OpGen Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners Talkspace UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation. Which has more risk and volatility, UPHL or BTTX? UpHealth has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Which has stronger earnings & valuation, UPHL or BTTX? Better Therapeutics has lower revenue, but higher earnings than UpHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpHealth$130M0.00-$56.42M-$1.350.00Better TherapeuticsN/AN/A-$39.76MN/AN/A Is UPHL or BTTX more profitable? Company Net Margins Return on Equity Return on Assets UpHealthN/A N/A N/A Better Therapeutics N/A N/A N/A Does the media favor UPHL or BTTX? In the previous week, UpHealth had 1 more articles in the media than Better Therapeutics. MarketBeat recorded 1 mentions for UpHealth and 0 mentions for Better Therapeutics. UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score. Company Overall Sentiment UpHealth Neutral Better Therapeutics Neutral Do institutionals & insiders have more ownership in UPHL or BTTX? 56.1% of UpHealth shares are held by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Comparatively, 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryUpHealth and Better Therapeutics tied by winning 3 of the 6 factors compared between the two stocks. Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BTTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTTX vs. The Competition Export to ExcelMetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$5K$70.06M$5.74B$9.56BDividend YieldN/AN/A4.53%4.07%P/E RatioN/AN/A30.4325.14Price / SalesN/A8.99392.4187.63Price / CashN/A4.0237.0358.50Price / BookN/A1.158.956.21Net Income-$39.76M-$30.80M$3.26B$265.38M7 Day PerformanceN/A-11.92%1.03%-1.12%1 Month PerformanceN/A-4.22%4.28%-0.68%1 Year PerformanceN/A483.24%28.38%18.92% Better Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTTXBetter TherapeuticsN/A$0.00flatN/A-50.0%$5KN/A0.0040UPHLUpHealth0.364 of 5 stars$0.00flatN/A-99.9%$4K$130M0.001,750OPGNOpGenN/AN/AN/A-100.0%$1K$2.67M0.00100ACONWAclarionN/A$0.05+14.2%N/A+62.8%$0.00$54.60K0.007AONCAmerican Oncology NetworkN/A$10.50-14.2%N/A+251.1%$0.00$1.34B0.001,520DHACWDigital Health AcquisitionN/A$0.05-9.0%N/AN/A$0.00N/A0.00N/AGap DownFMSFresenius Medical Care AG & Co. KGaA3.1601 of 5 stars$24.86+2.7%$27.80+11.8%+34.9%$0.00$20.63B20.381,384Analyst DowngradeShort Interest ↑Gap UpLFMDPLifeMDN/A$23.65+0.8%N/A+9.4%$0.00$245.56M0.00230OTRKPOntrakN/A$0.02flatN/A-90.6%$0.00$10.84M0.00250High Trading VolumePIIIWP3 Health PartnersN/A$0.01+4.0%N/A-55.1%$0.00$1.49B0.00500Positive NewsHigh Trading VolumeTALKWTalkspaceN/A$0.07+0.3%N/A+40.9%$0.00$202.61M0.00500Positive NewsGap UpHigh Trading Volume Related Companies and Tools Related Companies UPHL Alternatives OPGN Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives FMS Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTTX) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access